ANGLE PLC's (LON:AGL) CEO Andrew Newland and finance director Ian Griffiths present at the Proactive One2One Virtual Conference. ANGLE develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of disease.
29 Aug 20